← feed

Is NCT03443895 results overdue?

Yes — results are overdue. Primary completion was 2018-05-01; the FDAAA-801 reporting deadline (2019-05-01) passed 2654 days ago and no results are posted on ClinicalTrials.gov.

Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

NCT IDNCT03443895 ↗
SponsorAelis Farma (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-05-01 (ACTUAL)
Reporting deadline2019-05-01 (completion + 365d)
Days overdue2654
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 e2fde561c2360b81… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03443895. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →